Old Web
English
Sign In
Acemap
>
authorDetail
>
Pam J. Cheshire
Pam J. Cheshire
Chemistry
Pharmacology
Topotecan
Diabetes mellitus
Probenecid
4
Papers
87
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Importance of Tumor Glucuronidase in the Activation of Irinotecan in a Mouse Xenograft Model
2002
Journal of Pharmacology and Experimental Therapeutics
Helen M. Dodds
Peter Tobin
Clinton F. Stewart
Pam J. Cheshire
Suzan K. Hanna
Peter J. Houghton
Laurent P. Rivory
Show All
Source
Cite
Save
Citations (13)
Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines
1999
Cancer Chemotherapy and Pharmacology
William C. Zamboni
P. J. Houghton
Jeff L. Hulstein
Mark N. Kirstein
Jessica Walsh
Pam J. Cheshire
Suzan K. Hanna
Mary K. Danks
Clinton F. Stewart
Show All
Source
Cite
Save
Citations (39)
Probenecid Alters Topotecan Systemic and Renal Disposition by Inhibiting Renal Tubular Secretion
1998
Journal of Pharmacology and Experimental Therapeutics
William C. Zamboni
P. J. Houghton
Randall K. Johnson
Jeff L. Hulstein
William R. Crom
Pam J. Cheshire
Suzan K. Hanna
Lois B. Richmond
Xiaolong Luo
Clinton F. Stewart
Show All
Source
Cite
Save
Citations (34)
Probenecid alters topotecan (TPT) systemic and renal disposition
1997
Clinical Pharmacology & Therapeutics
William C. Zamboni
P. J. Houghton
Randall K. Johnson
Jeff L. Hulstein
William R. Crom
Pam J. Cheshire
Lois B. Richmond
Clinton F. Stewart
Show All
Source
Cite
Save
Citations (1)
1